• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

参与产生TRK致癌基因的染色体重排的NTRK1基因组区域的特征分析。

Characterization of the NTRK1 genomic region involved in chromosomal rearrangements generating TRK oncogenes.

作者信息

Greco A, Mariani C, Miranda C, Pagliardini S, Pierotti M A

机构信息

Division of Experimental Oncology A, Istituto Nazionale Tumori, Milan, Italy.

出版信息

Genomics. 1993 Nov;18(2):397-400. doi: 10.1006/geno.1993.1482.

DOI:10.1006/geno.1993.1482
PMID:8288244
Abstract

TRK oncogenes are created by chromosomal rearrangements linking the tyrosine-kinase domain of the NTRK1 gene (encoding one of the receptors for the nerve growth factor) to foreign activating sequences. TRK oncogenes are frequently detected in human papillary thyroid carcinoma, as result of rearrangements involving at least three different activating genes. We have found that the rearrangements creating all the TRK oncogenes so far characterized fall within a 2.9-kb XbaI/SmaI restriction fragment of the NTRK1 gene. Here we report the nucleotide sequence and the exon organization of this fragment.

摘要

TRK癌基因是由染色体重排产生的,这些重排将NTRK1基因(编码神经生长因子的一种受体)的酪氨酸激酶结构域与外源激活序列连接起来。由于涉及至少三种不同激活基因的重排,TRK癌基因在人甲状腺乳头状癌中经常被检测到。我们发现,迄今为止所鉴定的所有产生TRK癌基因的重排都位于NTRK1基因的一个2.9 kb XbaI/SmaI限制性片段内。在此,我们报告该片段的核苷酸序列和外显子组织。

相似文献

1
Characterization of the NTRK1 genomic region involved in chromosomal rearrangements generating TRK oncogenes.参与产生TRK致癌基因的染色体重排的NTRK1基因组区域的特征分析。
Genomics. 1993 Nov;18(2):397-400. doi: 10.1006/geno.1993.1482.
2
Chromosome 1 rearrangements involving the genes TPR and NTRK1 produce structurally different thyroid-specific TRK oncogenes.涉及TPR和NTRK1基因的1号染色体重排产生结构不同的甲状腺特异性TRK致癌基因。
Genes Chromosomes Cancer. 1997 Jun;19(2):112-23.
3
A sequence analysis of the genomic regions involved in the rearrangements between TPM3 and NTRK1 genes producing TRK oncogenes in papillary thyroid carcinomas.对甲状腺乳头状癌中产生TRK致癌基因的TPM3和NTRK1基因重排所涉及的基因组区域进行序列分析。
Genomics. 1995 Jul 1;28(1):15-24. doi: 10.1006/geno.1995.1100.
4
Genomic organization of the human NTRK1 gene.人类神经营养酪氨酸激酶受体1(NTRK1)基因的基因组结构
Oncogene. 1996 Dec 5;13(11):2463-6.
5
The trk family of oncogenes and neurotrophin receptors.癌基因与神经营养因子受体的trk家族。
Princess Takamatsu Symp. 1991;22:153-70.
6
Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident.切尔诺贝利核事故暴露儿童的甲状腺乳头状癌中RET原癌基因的致癌重排
Cancer Res. 1995 Dec 1;55(23):5617-20.
7
The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain.产生TRK - T3癌基因的DNA重排涉及3号染色体上的一个新基因,其产物具有潜在的卷曲螺旋结构域。
Mol Cell Biol. 1995 Nov;15(11):6118-27. doi: 10.1128/MCB.15.11.6118.
8
TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas.TRK-T1是一种在人甲状腺乳头状癌中由TPR基因与TRK基因融合形成的新型致癌基因。
Oncogene. 1992 Feb;7(2):237-42.
9
Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.通过与细胞粘附分子融合,人trk原癌基因酪氨酸激酶结构域的致癌激活。
Oncogene. 1996 Oct 17;13(8):1755-63.
10
Structure and organization of the human TRKA gene encoding a high affinity receptor for nerve growth factor.编码神经生长因子高亲和力受体的人类TRKA基因的结构与组织
Jpn J Hum Genet. 1997 Jun;42(2):343-51. doi: 10.1007/BF02766957.

引用本文的文献

1
Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance.实体瘤中的融合基因:诊断策略、靶向治疗及获得性耐药
Nat Rev Clin Oncol. 2017 Dec;14(12):735-748. doi: 10.1038/nrclinonc.2017.127. Epub 2017 Aug 31.
2
(R)-2-Phenylpyrrolidine Substituted Imidazopyridazines: A New Class of Potent and Selective Pan-TRK Inhibitors.(R)-2-苯基吡咯烷取代的咪唑并哒嗪类:一类新型强效且选择性的泛TRK抑制剂。
ACS Med Chem Lett. 2015 Mar 16;6(5):562-7. doi: 10.1021/acsmedchemlett.5b00050. eCollection 2015 May 14.
3
Detecting and targetting oncogenic fusion proteins in the genomic era.
基因组时代对致癌融合蛋白的检测与靶向治疗
Biol Cell. 2015 May;107(5):111-29. doi: 10.1111/boc.201400096. Epub 2015 Apr 7.
4
TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts.GNF-4256对TrkB的抑制作用可减缓神经母细胞瘤异种移植瘤的生长并增强化疗疗效。
Cancer Chemother Pharmacol. 2015 Jan;75(1):131-41. doi: 10.1007/s00280-014-2627-1. Epub 2014 Nov 14.
5
Discovery of GNF-5837, a Selective TRK Inhibitor with Efficacy in Rodent Cancer Tumor Models.GNF-5837的发现,一种在啮齿动物癌症肿瘤模型中具有疗效的选择性TRK抑制剂。
ACS Med Chem Lett. 2012 Jan 1;3(2):140-5. doi: 10.1021/ml200261d. eCollection 2012 Feb 9.
6
AZ64 inhibits TrkB and enhances the efficacy of chemotherapy and local radiation in neuroblastoma xenografts.AZ64 抑制 TrkB 并增强神经母细胞瘤异种移植物中化疗和局部放疗的疗效。
Cancer Chemother Pharmacol. 2012 Sep;70(3):477-86. doi: 10.1007/s00280-012-1879-x. Epub 2012 May 24.
7
Suitability of animal models for studying radiation-induced thyroid cancer in humans: evidence from nuclear architecture.从核架构看用于研究人类辐射诱导甲状腺癌的动物模型的适宜性:证据。
Thyroid. 2011 Dec;21(12):1331-7. doi: 10.1089/thy.2011.0269.
8
Activation of amyloid precursor protein processing by growth factors is dependent on Ras GTPase activity.生长因子通过 Ras GTP 酶活性激活淀粉样前体蛋白的加工。
Neurochem Res. 2011 Mar;36(3):392-8. doi: 10.1007/s11064-010-0343-8. Epub 2010 Dec 15.
9
c.1810C>T polymorphism of NTRK1 gene is associated with reduced survival in neuroblastoma patients.NTRK1 基因的 c.1810C>T 多态性与神经母细胞瘤患者的生存降低相关。
BMC Cancer. 2009 Dec 13;9:436. doi: 10.1186/1471-2407-9-436.
10
Gene position within chromosome territories correlates with their involvement in distinct rearrangement types in thyroid cancer cells.基因在染色体区域内的位置与其在甲状腺癌细胞中不同重排类型的参与情况相关。
Genes Chromosomes Cancer. 2009 Mar;48(3):222-8. doi: 10.1002/gcc.20639.